Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

necrosis/protease

Tautan disimpan ke clipboard
11 hasil

Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS REFERENCE TO RELATED APPLICATION This application is a National Stage of International Application No. PCT/KR2011/009914 filed Dec. 21, 2011, claiming priority based on Korean Patent Application No. 10-2010-0132955 filed Dec. 23, 2010, the contents of all of which are incorporated herein by

Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Stage of International Application No. PCT/KR2010/007160 filed on Oct. 19, 2010, which claims priority from Korean Patent Application No. 10-2009-0099219, filed on Oct. 19, 2009, the contents of all of which are incorporated

24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The present invention relates to proteases involved in apoptosis signalling pathways, to processes for the purification of the proteases, and more particularly to methods for the use of the proteases to modulate apoptosis in target cells. BACKGROUND OF THE INVENTION Necrosis

Blockade of inflammatory proteases with cyclic peptides

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION This invention relates to the use of cyclic peptides for modulating cytokine activity, including signaling and inflammatory pathways, in various diseases. More particularly, cyclic peptides possess hereto unknown biological activities, such as inhibition of sheddases and other

Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION 1. Technical Field of the Invention This invention relates generally to cytoenzymology, and more particularly to methods and reagents used in cytoenzymology. 2. Discussion of the Background Art Apoptosis, or programmed cell death, is a process that involves the activation

Composition for collecting and preserving placental stem cells and methods of using the composition

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
1. INTRODUCTION The present invention relates to improved methods and compositions for the collection of placental stem cells, e.g., by perfusion or physical and/or enzymatic disruption of a placenta or a part thereof, and methods of collecting the stem cells using the compositions. The compositions

Composition for collecting placental stem cells and methods of using the composition

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
1. INTRODUCTION The present invention relates to improved methods and compositions for the collection of placental stem cells, e.g., by perfusion or physical and/or enzymatic disruption of a placenta or a part thereof, and methods of collecting the stem cells using the compositions. The compositions
FIELD OF THE INVENTION This invention relates to secretion of heterologous bioactive proteins, in particular, granulocyte macrophage colony stimulating factor ("GM-CSF") by an expression system inserted into a host selected from the Streptomyces genera. BACKGROUND OF THE INVENTION In producing

Use of tumor factor inhibitors together with antiviral agents and therapeutic compositions thereof against HIV infection

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to de novo compositions of matter for the treatment of AIDS. The present invention further relates to the de novo compositions of matter containing TNF inhibitors and antiviral agents selected from the group of reverse transcriptase inhibitors, protease inhibitors, gene

Combination therapy for conditions leading to bone loss

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The invention relates generally to polypeptides involved in the regulation of bone metabolism. More particularly, the invention relates to a novel polypeptide, termed osteoprotegerin, which is a member of the tumor necrosis factor receptor superfamily. The polypeptide is used

TNF-.alpha. converting enzyme inhibitory agents and method of using same

Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION The invention relates to the field of metalloproteases. Specifically, the invention relates to activation or inhibition of the ADAM family of proteases. More specifically, the invention relates to activation or inhibition of the TNF-.alpha. converting enzyme (TACE). BACKGROUND
Bergabunglah dengan
halaman facebook kami

Database tanaman obat terlengkap yang didukung oleh sains

  • Bekerja dalam 55 bahasa
  • Pengobatan herbal didukung oleh sains
  • Pengenalan herbal melalui gambar
  • Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
  • Baca publikasi ilmiah yang terkait dengan pencarian Anda
  • Cari tanaman obat berdasarkan efeknya
  • Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten

Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan

Google Play badgeApp Store badge